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with respiratory insufficiency. The prognosis is good in 90% of casesI 3 although recovery may take several 12 N . . years . 0 Improvement was seen m our patient during the 9 months between investigations. It is important to monitor such cases, so that if deterioration should later occur, nocturnal ventilatory support can be considered.
This case demonstrates that a patient with diaphragm weakness may have only mild orthopnoea and minimal breathlessness on exertion!" and that unless the diagnosis is considered it may easily be overlooked. 12 (500mg 12·hourly) and metronidazole (500mg 8·hourly) were started, and there was some initial improvement in the foot and reduction of the fever. However, in spite of peak amikacin levels of 20-30 mg/l, the toe became progressively worse and by 7.9.84her temperature again rose to 39°C. Blood cultures at this time grew the same resistant Ps. aeruginosa present in the toe. Both isolates were indistinguishable by serology, though untypable by phage typing. The patient became increasingly unwell, and on 10.9.84she was clinically shocked with a fever of 39.5°C. Ciprofloxacin was commenced at a dose of 200mg intravenously 12·hourIy in addition to amikacin and metronidazole. Daily granulocyte transfusions were also given over the next week. Minimum inhibitory concentrations (MICs) of ciprofloxacin and amikacin to the Ps. aeruginosa were 0.25mg/l and 4.0mg/l respectively. These were determined using Iso-sensitest broth.
By 12 hours after starting ciprofloxacin there was a definite clinical improvement and after 4 days she became afebrile. All antibiotics were stopped on 18.9.84 (after 8 days of ciprofloxacin). The toe gradually healed following surgical debridement, but the resistant Ps. aeruginosa was not eradicated from the site.
A widespread rash developed 6 days after starting ciprofloxacin but was not severe enough to necessi- Although both developed rashes, ciprofloxacin could not be definitely incriminated, particularly as in the second patient the rash did not recur during his second course of ciprofloxacin.
In both patients, serum concentrations of ciprofloxacin were measured by high pressure liquid chromatography (Figure 1 ). Both graphs show that the half-life of ciprofloxacin given intravenously was of the order of 2 hours. Furthermore, with the dose of 200mg, the serum levels fell to the MIC (0.25mgjI) after 10 and 6 hours in the first and second patient respectively. We suggest, therefore, that an 8-hourly regimen may be more appropriate than 12-hourly (as was tried in the last 2 weeks of the second patient's illness). Gonzalez et al. 5 , in a study of the pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers, also concluded that an 8hourly, rather than 12-hourly, regimen should be considered for serious pseudomonal infections. tate discontinuing the drug. It resolved rapidly after stopping ciprofloxacin.
Case 2: A 17-year-old boy was treated with intensive cytotoxic chemotherapy for a second relapse of acute lymphoblastic leukaemia. A week after finishing chemotherapy, on 2.7.85, the patient was profoundly neutropenic (0.3 x 10 9/1). A nodule, 2 cm in diameter with a central necrotic area and surrounding cellulitis, developed in the right axilla. The patient developed a fever of 38.8°C associated with rigors. Three sets of blood cultures and a swab from the lesion grew Ps. aeruginosa, resistant to gentamicin, tobramycin, piperacillin, ceftazidime, cefotaxime and sensitive only to amikacin and ciprofloxacin. . , The patient was accordingly started on amikacin (350mg 12-hourly) and ciprofloxacin (200mg 12hourly). In addition he received a 5-day course of granulocyte transfusions. MICs of ciprotloxacin and amikacin to the Ps. aeruginosa were 0.25mgll and 0.5 mgll respectively. After 5 days' treatment the patient became afebrile, and after a further 3days the lesion in the axilla had shrunk, and the cellulitis had completely resolved. Ciprotloxacin was discontinued after a further week. A further 5-day course of cytotoxic chemotherapy was given since the patient was still not in remission and he remained severely neutropenic (0.2 x 10 9/i). He remained on amikacin with satisfactory blood levels (peak level of18.5 mg/l).
On 27.7.85, 9 days after stopping ciprofloxacin, the lesion in the axilla flared up. The patient developed a fever of 40°C, and once again Ps. aeruginosa was isolated from two sets of blood cultures. This isolate had the same antibiotic sensitivities as previously. All isolates were subsequently shown to be indistinguishable by serology though untypable by phage typing. Ciprotloxacin was restarted at a dose of 200mg 12-hourly, but in the absence of clinical improvement the dose was increased to 200mg 8hourly two days later. No remission was obtained and the patient remained neutropenic. His general condition deteriorated and he died on 13.8.85.
During his first course of ciprofloxacin and amik~ cin the patient had developed a widespread rash. Th.ls resolved soon after stopping the antibiotics and did not recur when ciprofloxacin was used a second time.
Discussion
In the first patient, a resistant Ps. aeruginosa spread from the toe despite adequate blood levels of amikacin to which it was sensitive in vitro. At the time of starting ciprofloxacin she was seriously ill with a pseudomonal septicaemia. The addition of ciprofloxacin and granulocyte transfusions to the amikacin and metronidazole was undoubtedly effective in her recovery. The part played by the granulocyte transfusions is impossible to determine in this case. The efficacy of granulocyte transfusions in neutropenic patients remains controversial". In the second patient, the combination of ciprotloxacin, a~~k~cin and granulocyte transfusions was at .Ieast lmtlallẽ ffective in that it cured the first episode of septicaemia. However, the skin lesion never completely healed and following his second course of cytotoxic chemother~py, all antibiotics failed. Both patients tolerated ciprofloxacin well, with no significant rise in plasma aspartate transaminase, alkaline phosphatase, urea or creatinine during their treatment.
